Merck CEO Rob Davis expressed high confidence during the company’s J.P. Morgan presentation on Monday, revealing that the ...
A key number for Merck in the coming years is $70 billion. This is the mid-2030s revenue opportunity from potential new ...
The company’s previous CCO was Cristal Downing, who joined Insulet as chief corporate affairs officer late last year.
Investors poured into a room at #JPM26 to see how Revolution Medicines' CEO would dance around questions they knew he ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback